Patent 12031894

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-flash

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

1 active
  • IPR2026-00150IPRfiled Nov 25, 2025vs. Sarepta Therapeutics, Inc. et al.Trial Instituted

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (1)

Group view →

Specific litigation cases in our database that name US patent 12031894. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

As a patent attorney, I have identified the following known litigation involving US patent 12031894:

Patent Trial and Appeal Board (PTAB) Case:

  • Case Number: IPR2026-00150
  • Plaintiff(s): Petitioner (not explicitly named in the provided snippets)
  • Defendant(s): Genzyme Corporation et al. (Patent Owner/Respondent)
  • Jurisdiction: Patent Trial and Appeal Board (PTAB) of the USPTO
  • Filing Date: Not explicitly stated in the provided snippets, but the Decision Issue Date is May 6, 2026.
  • Outcome or Current Status: Institution Granted.

Generated 5/27/2026, 6:45:30 AM